AstraZeneca and GEA Farmaceutisk Fabrik: ECJ 16 Oct 2003

(Judgment) Medicinal products – Marketing authorisation of a generic medicinal product – Withdrawal of the marketing authorisation of the reference medicinal product – Abridged procedure

Citations:

C-223/01, [2003] EUECJ C-223/01, [2003] ECR I-11809, [2003] ECR I-11809

Links:

Bailii

Jurisdiction:

European

Licensing, Health

Updated: 29 April 2022; Ref: scu.187153